Article Details

BioVaxys: Using T-Cell Immune Response for Vaccine Development

Retrieved on: 2020-12-29 03:56:03

Tags for this article:

Click the tags to see associated articles and topics

BioVaxys: Using T-Cell Immune Response for Vaccine Development. View article details on hiswai:

Excerpt

BioVaxys, a biotechnology company and world leader in the development of haptenized protein vaccines, has developed a technology platform ...

Article found on: www.sciencetimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo